Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Novo Nordisk's exclusive hold on semaglutide - the active ingredient in popular fat-busting GLP-1 jabs such as Wegovy and Ozempic - expired last Friday.